Cardiovascular devices are used in treating diseases related to the heart and the circulatory system. Carotid and renal artery stents are expandable tubes that are implanted in narrowed arteries to increase the flow of blood. GlobalData uses proprietary data and analytics to provide a comprehensive report on the carotid and renal artery stents devices market, including market shares of different players within New Zealand. Buy the latest report here.
Smarter leaders trust GlobalData
In 2022, GlobalData’s Market Model methodology determined that the leading player in the carotid and renal artery stents market in New Zealand was Abbott Laboratories followed by Boston Scientific, Terumo, Biotronik SE, Medtronic, Cardinal Health and Cook Medical.
Carotid arteries become narrowed due to plaque formation and buildup in the inner surface of the arteries. Carotid stenosis is further divided into two indications: symptomatic and asymptomatic carotid stenosis. Patients with symptomatic carotid stenosis can present with symptoms such as transient ischemic attacks or temporary vision loss. But in cases of asymptomatic carotid stenosis, there are no such symptoms. Carotid artery stenosis is a major contributor to ischemic stroke. Renal artery stents are expandable tubes that are implanted to increase blood flow in the narrowed renal artery. Renal arteries can become narrowed due to plaque formation in the inner surface of the arteries. A Carotid artery BMS is a metal-mesh tube that is implanted to increase the flow of blood in a narrowed carotid artery. A Renal artery BMS is a metal-mesh tube that is implanted to increase blood flow in a narrowed renal artery. Transcarotid Stent System is a nitinol self- expanding stent that is implanted to form a lattice to cover narrowed carotid artery and to push outward on the luminal surface, helping to maintain the carotid artery.
Following the widespread disruption resulting from the COVID-19 pandemic to the broader medical devices market during 2020 and 2021, the value of the carotid and renal artery stents devices market within New Zealand was expected to be over $0.8m in 2022.
For the latest complete market share analysis of carotid and renal artery stents device market in New Zealand, buy the report here.
Premium Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
The medical devices pipeline data used in this article were obtained from the Medical Pipeline Products Database of GlobalData’s Medical Intelligence Center. Pipeline Products database is a comprehensive source of information on medical devices, it covers 39K products which are in development stage and intended for diagnosis, treatment, and management of diseases/conditions/symptoms directly or indirectly. The pipeline products included in the database are sourced from reliable and authenticated sources, such as company websites, SEC filings, conference presentations, analyst presentations, news releases, clinical trial registries, and grants. The information is collected by following systematic research techniques and proprietary methodology.
